Forbes Medi-Tech




Previous All pages Next 1 2 3 4 5 6 Page 7 8 9
June 03, 2004  Forbes Achieves Major Milestone Towards New Zealand & Australian Approval of Reducol(tm)
May 27, 2004  Forbes Medi-Tech Appoints Don Buxton as Chairman of the Board
May 17, 2004  Forbes Medi-Tech announces Financial Results for the Quarter ended March 31, 2004
April 26, 2004  CIBC World Markets Audio Broadcast of Forbes Medi-Tech Inc. Presentation at the Annual Biotechnology & Specialty Pharmaceuticals Conference
April 20, 2004  Forbes Medi-Tech announces Financial Results for the Year ended December 31, 2003
April 19, 2004  Forbes Medi-Tech Announces Timing of Year End Financial Results and AGM
April 19, 2004  Forbes Medi-Tech Announces Additional European Phase II Trial Data for FM-VP4
April 14, 2004  Forbes Medi-Tech Announces Second Milestone Completion for Reducol(tm) Sales in Europe
April 06, 2004  Forbes Medi-Tech to Present at CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference
April 05, 2004  Forbes Medi-Tech Announces European Phase II Trial Results for FM-VP4
April 02, 2004  Forbes Medi-Tech Announces Timing of European Phase II Clinical Trial Results
March 26, 2004  Forbes Medi-Tech Signs Reducol(tm) Licensing and Distribution Agreement with Marco Hi-Tech
February 19, 2004  Forbes Medi-Tech Increases Depth of its Medical & Scientific Advisory Board with Appointment of Four Key Leaders in Cardiovascular Research
February 09, 2004  Forbes Medi-Tech Completes Regulatory Filing Pursuant to Previous Financing
February 03, 2004  Forbes Medi-Tech Completes Dosing for Phase II clinical trial on FM-VP4
January 07, 2004  Forbes Medi-Tech Attracts Leading Cardiologist from Cleveland Clinic & Completes Equity Financing of US$10.75 Million
December 12, 2003  Forbes Achieves Major Milestone Towards European Approval of Reducol(tm)
December 09, 2003  Forbes Medi-Tech Expands Plant Capacity to 1,500 Metric Tonnes ~Demand for Sterols Supports Phyto-Source Expansion~
December 03, 2003  Forbes Medi-Tech Files U.S. Registration Statement Pursuant to Previous Financing
November 25, 2003  Forbes Medi-Tech announces Financial Results for the Third Quarter ended September 30, 2003
November 17, 2003  Forbes Medi-Tech Announces Timing of Third Quarter Financial Results
October 22, 2003  Forbes Medi-Tech Co-Sponsors CIHR Research Chair with Dr. Kishor Wasan
September 16, 2003  Forbes Medi-Tech Appoints New Member to Board of Directors
September 05, 2003  Forbes Medi-Tech Raises US$4.65 Million in Equity Financing
August 20, 2003  Forbes Medi-Tech Receives Approval for Nasdaq National Market Listing
Previous All pages Next 1 2 3 4 5 6 Page 7 8 9